Skip to main content
Premium Trial:

Request an Annual Quote

Belgium's VIB to Use Biogazelle qPCR Data-analysis Software

Premium

BITS, the bioinformatics training and service facility of Belgium's Vlaams Instituut voor Biotechnologie, or VIB, will use Biogazelle's qbase+ software for PCR analysis, Biogazelle said this week.

Under a group license, qbase+ is now available to more than 1,000 researchers from more than 10 VIB departments.

Based on peer-reviewed geNorm and qBase technology developed by Ghent University's Jo Vandesompele and Jan Hellemans, qbase+ is qPCR data-analysis software designed for mRNA gene expression profiling and analysis, miRNA profiling and validation studies, and gene copy number analysis, among other applications.

"Qbase+ will allow us to improve the accuracy of our results and bring our qPCR-based research to a higher level," Herwig Van Marck, director of BITS, said in a statement. "The peer-reviewed software algorithms will help our researchers to annotate and process qPCR data according to international guidelines."

Van Marck added that the group can ensure data quality by using various calculations available in qbase+ for post-PCR quality control, PCR efficiency correction, normalization, inter-run calibration, and statistics.

Biogazelle, based in Zwijnaarde, Belgium, said that it will also provide training sessions and expertise to qPCR users within VIB.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.